Alpha Cognition Q2 FY26 net loss narrows to $8.8 million; revenue rises 71% qoq to $6 million
ACOG•Q2 revenue rises as ZUNVEYL demand climbs
- Alpha Cognition posted Q2 revenue of $6 million, up about 71% quarter-over-quarter as ZUNVEYL demand climbed.
- Net loss narrowed to $8.8 million, or $(0.40) per share, from $13.2 million, or $(0.82) per share, a year earlier.
- ZUNVEYL bottles dispensed rose about 37% sequentially to 8,294, with June demand reaching 2,997.
- Quarterly prescribers increased about 26% to 1,347, while repeat prescribers climbed about 29% to 1,024.
- Cash and cash equivalents were $41.4 million at June 30; full-year 2026 R&D and SG&A guidance cut to $50-$54 million.
Related News
Kochav Defense Acquisition FY26 Q2 net income rises to $2.13 million
KCHV•
Synchrony names Nimrod Barak as chief AI officer
SYF•
